Defunct Company
Total Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
32,207
NCT01720277
High Dose Influenza Vaccine in Nursing Home - Pilot Study
Phase: Phase 4
Role: Lead Sponsor
Start: Sep 30, 2012
Completion: May 31, 2016
NCT01815268
High-Dose Influenza Vaccine in Nursing Homes
Start: Feb 28, 2013
Completion: Sep 30, 2018
NCT02882100
Adjuvanted Influenza Vaccination in U.S. Nursing Homes
Start: Apr 30, 2016
Completion: Jan 25, 2023
NCT02933723
Immunogenicity of Influenza Vaccine in Long Term Care
Phase: N/A
Start: Oct 31, 2016
Completion: Sep 1, 2021
NCT03209570
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Start: Oct 19, 2017
Completion: Aug 11, 2018
NCT03599739
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
Start: Jul 13, 2018
NCT03965195
Recombinant Influenza Vaccination in U.S. Nursing Homes
Start: Jul 20, 2019
Completion: Dec 31, 2023
NCT04732819
Improving COVID-19 Vaccine Uptake in Nursing Homes
Role: Collaborator
Start: Dec 21, 2020
Completion: Apr 16, 2021
NCT05012189
Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks
Start: Aug 6, 2021